Transtek(SZ:300562) Sou Hu Cai Jing·2025-05-12 09:58Group 1 - The core viewpoint of the news highlights the performance and valuation of Leksin Medical, indicating a recent stock price increase and a low rolling PE ratio compared to the industry average [1][2]. - As of May 12, Leksin Medical's stock closed at 14.85 yuan, up 2.70%, with a rolling PE ratio of 45.72, marking a new low in 24 days and a total market capitalization of 3.229 billion yuan [1]. - The average PE ratio for the medical device industry is 49.84, with a median of 36.59, positioning Leksin Medical at the 87th rank within the industry [1][3]. Group 2 - Leksin Medical specializes in health IoT and digital health services, offering products such as smart electronic blood pressure monitors, health scales, and ECG monitoring devices [2]. - The company is recognized as a national high-tech enterprise and has established several engineering technology research centers, focusing on the R&D, production, and sales of home medical health electronic products [2]. - In the latest quarterly report for Q1 2025, Leksin Medical reported revenue of 273 million yuan, a year-on-year increase of 9.90%, and a net profit of 22.942 million yuan, reflecting a significant year-on-year growth of 67.88% with a gross profit margin of 37.38% [2].